Benzinga | May 6, 2021 05:01PM EDT

NGM Biopharmaceuticals Q1 EPS $(0.36) Down From $(0.28) YoY, Sales $21.57M Down From $24.36M YoY

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.36) per share. This is a 28.57 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $21.57 million in sales this quarter. This is a 11.45 percent decrease over sales of $24.36 million the same period last year.